GeneDx (WGS) has had the highest return since March 14, 2024 by a mid-cap US stock, returning 810.1%.
| ASSET | % RETURN |
|---|---|
GeneDx (WGS) | 810.07% |
Ast Spacemobile (ASTS) | 793.65% |
VNET Group Inc DRC (VNET) | 497.44% |
Rigetti Computing (RGTI) | 434.29% |
Kingsoft Cloud Holdings (KC) | 434.26% |
D-Wave Quantum (QBTS) | 357.21% |
Rocket Lab USA (RKLB) | 339.49% |
GDS (GDS) | 338.68% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 320.38% |
Verona Pharma PLC ADR (VRNA) | 270.94% |
Root (ROOT) | 221.73% |
Alignment Healthcare LLC (ALHC) | 217.07% |
ADMA Biologics (ADMA) | 197.26% |
Lumen Technologies (LUMN) | 196.95% |
Brinker International (EAT) | 188.39% |
Carpenter Technology (CRS) | 183.72% |
BBVA Banco Frances SA ADR (BBAR) | 178.18% |
TG Therapeutics (TGTX) | 162.47% |
IONQ (IONQ) | 158.26% |
SSR Mining (SSRM) | 157.69% |
Oklo (OKLO) | 155.96% |
360 DigiTech (QFIN) | 152.99% |
Credo Technology (CRDO) | 145.26% |
Bloom Energy (BE) | 143.48% |
Lufax (LU) | 142.47% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
